Simple Summary The prognostic relevance of a patient achieving complete response to hydroxyurea, the predictors of response, and patients' triggers for switching to ruxolitinib are uncertain. A retrospective, real-world analysis was performed on 563 polycythemia vera patients treated with hydroxyurea for & GE;12 months during an observational...
-
2023 (v1)PublicationUploaded on: February 4, 2024
-
2023 (v1)Publication
BackgroundPatients with cytopenic myelofibrosis (MF) have more limited therapeutic options and poorer prognoses compared with patients with the myeloproliferative phenotype. Aims and MethodsPrognostic correlates of cytopenic phenotype were explored in 886 ruxolitinib-treated patients with primary/secondary MF (PMF/SMF) included in the RUX-MF...
Uploaded on: February 4, 2024 -
2023 (v1)Publication
No description
Uploaded on: February 4, 2024